SCHEMBL26779098

SCHEMBL26779098

CC(C)N(CC(=O)O)C(=O)CF

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ GABRP O00591 2/20 0.32
▸ GABRD O14764 2/20 0.32
▸ GABRA1 P14867 2/20 0.32
▸ GABRB1 P18505 2/20 0.32
▸ GABRG2 P18507 2/20 0.32
▸ GABRB3 P28472 2/20 0.32
▸ GABRA5 P31644 2/20 0.32
▸ GABRA3 P34903 2/20 0.32
▸ GABRA2 P47869 2/20 0.32
▸ GABRB2 P47870 2/20 0.32
▸ GABRA4 P48169 2/20 0.32
▸ GABRE P78334 2/20 0.32
▸ GABRA6 Q16445 2/20 0.32
▸ GABRG1 Q8N1C3 2/20 0.32
▸ GABRG3 Q99928 2/20 0.32
▸ GABRQ Q9UN88 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ EYA2 O00167 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26773180 0.78 ALDH1A1 (0.43) MEN1KMT2AGABRPGABRDGABRA1
SCHEMBL26779100 0.76 CA12 (0.42) KMT2AKDM4ELMNAALOX15
SCHEMBL9835163 0.75 TDP1 (0.36) MEN1KMT2ATDP1EYA2APP
SCHEMBL23544769 0.71 EPHX2 (0.36) MEN1KMT2AGABRPGABRDGABRA1
SCHEMBL20427851 0.71 ALDH1A1 (0.42) MEN1KMT2AEPHX2LMNAALOX15
SCHEMBL26773179 0.70 MVD (0.43) TDP1EYA2APPACEKDM4E
SCHEMBL20187495 0.70 HSD17B10 (0.39) MEN1KMT2AKDM4E
SCHEMBL19318549 0.70 TSHR (0.39) MEN1KMT2ATDP1EYA2APP
SCHEMBL29834095 0.69 HSD17B10 (0.38) MEN1KMT2AKDM4E
SCHEMBL17666032 0.68 TDP1 (0.31) MEN1KMT2ATDP1EYA2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023215559-A1 COMPOUNDS, COMPOSITIONS, AND METHODS ARIA PHARMACEUTICALS, INC. (US) 2023-11-09 — — WO disclosed
Send feedback